Cefminox

Антимикробная активность

A semisynthetic cephamycin. Activity is similar to that of cefoxitin and cefotetan, but the activity against enterobacteria and B. fragilis is somewhat better . C. difficile is inhibited by 4–16 mg/L. It is stable to the common β-lactamases of enterobacteria and Bacteroides spp.
A 15-min intravenous infusion of 1 g achieves a serum concentration of 30 mg/L after 1 h. The plasma half-life is c. 2 h and around 68% is protein bound.
Its safety profile and uses are similar to those of other cephamycins. It is available in Japan.